Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
245.05
-5.80 (-2.31%)
Feb 12, 2026, 11:23 AM EST - Market open
Insulet Revenue
Insulet had revenue of $706.30M in the quarter ending September 30, 2025, with 29.86% growth. This brings the company's revenue in the last twelve months to $2.52B, up 27.12% year-over-year. In the year 2024, Insulet had annual revenue of $2.07B with 22.07% growth.
Revenue (ttm)
$2.52B
Revenue Growth
+27.12%
P/S Ratio
6.99
Revenue / Employee
$646,615
Employees
3,900
Market Cap
17.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.07B | 374.50M | 22.07% |
| Dec 31, 2023 | 1.70B | 391.80M | 30.02% |
| Dec 31, 2022 | 1.31B | 206.50M | 18.79% |
| Dec 31, 2021 | 1.10B | 194.40M | 21.49% |
| Dec 31, 2020 | 904.40M | 166.20M | 22.51% |
| Dec 31, 2019 | 738.20M | 174.40M | 30.93% |
| Dec 31, 2018 | 563.80M | 100.00M | 21.56% |
| Dec 31, 2017 | 463.80M | 96.81M | 26.38% |
| Dec 31, 2016 | 366.99M | 103.10M | 39.07% |
| Dec 31, 2015 | 263.89M | 32.57M | 14.08% |
| Dec 31, 2014 | 231.32M | -15.76M | -6.38% |
| Dec 31, 2013 | 247.08M | 35.72M | 16.90% |
| Dec 31, 2012 | 211.37M | 59.11M | 38.83% |
| Dec 31, 2011 | 152.26M | 55.29M | 57.02% |
| Dec 31, 2010 | 96.97M | 30.93M | 46.85% |
| Dec 31, 2009 | 66.03M | 29.97M | 83.12% |
| Dec 31, 2008 | 36.06M | 22.69M | 169.66% |
| Dec 31, 2007 | 13.37M | 9.71M | 265.06% |
| Dec 31, 2006 | 3.66M | 3.61M | 7,226.00% |
| Dec 31, 2005 | 50.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Koninklijke Philips | 20.86B |
| GE HealthCare Technologies | 20.63B |
| Zimmer Biomet Holdings | 8.01B |
| Smith & Nephew | 5.94B |
| STERIS | 5.83B |
| DexCom | 4.52B |
| Globus Medical | 2.77B |
| Bio-Rad Laboratories | 2.56B |
PODD News
- 7 days ago - Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care - Business Wire
- 23 days ago - Is PODD A Better Bet Than ISRG Stock? - Forbes
- 4 weeks ago - Insulet Corporation (PODD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 - Business Wire
- 5 weeks ago - Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health - Business Wire
- 2 months ago - Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future - Business Wire
- 2 months ago - Eight stock picks to play one of the healthiest corners of the market - Market Watch